FR2786188B1 - Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments - Google Patents

Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Info

Publication number
FR2786188B1
FR2786188B1 FR9814782A FR9814782A FR2786188B1 FR 2786188 B1 FR2786188 B1 FR 2786188B1 FR 9814782 A FR9814782 A FR 9814782A FR 9814782 A FR9814782 A FR 9814782A FR 2786188 B1 FR2786188 B1 FR 2786188B1
Authority
FR
France
Prior art keywords
alkenyl
alkyl
alkynyl
radicals
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9814782A
Other languages
English (en)
French (fr)
Other versions
FR2786188A1 (fr
Inventor
Alexis Denis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel
Priority to FR9814782A priority Critical patent/FR2786188B1/fr
Priority to TW088119939A priority patent/TWI247747B/zh
Priority to AU59522/99A priority patent/AU772171B2/en
Priority to CA2290136A priority patent/CA2290136C/fr
Priority to US09/442,681 priority patent/US6440941B1/en
Priority to ZA9907176A priority patent/ZA997176B/xx
Priority to JP11331141A priority patent/JP2000159790A/ja
Priority to ES99402907T priority patent/ES2198867T3/es
Priority to DE69909577T priority patent/DE69909577T2/de
Priority to KR1019990052014A priority patent/KR100587445B1/ko
Priority to NO19995745A priority patent/NO314729B1/no
Priority to PT99402907T priority patent/PT1004592E/pt
Priority to AT99402907T priority patent/ATE245160T1/de
Priority to DK99402907T priority patent/DK1004592T3/da
Priority to RU99125547A priority patent/RU2237672C2/ru
Priority to MXPA99010813A priority patent/MXPA99010813A/es
Priority to HU9904392A priority patent/HUP9904392A3/hu
Priority to CNB99127394XA priority patent/CN1165546C/zh
Priority to IL133101A priority patent/IL133101A/en
Priority to EP99402907A priority patent/EP1004592B1/fr
Priority to ARP990105985A priority patent/AR021388A1/es
Priority to PL99336736A priority patent/PL336736A1/xx
Priority to BR9905735-2A priority patent/BR9905735A/pt
Priority to TR1999/02888A priority patent/TR199902888A3/tr
Publication of FR2786188A1 publication Critical patent/FR2786188A1/fr
Priority to US10/188,394 priority patent/US6664398B2/en
Application granted granted Critical
Publication of FR2786188B1 publication Critical patent/FR2786188B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR9814782A 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments Expired - Fee Related FR2786188B1 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW088119939A TWI247747B (en) 1998-11-24 1999-11-16 New derivatives of erythromycin, their preparation process and their use as medicaments
AU59522/99A AU772171B2 (en) 1998-11-24 1999-11-17 New derivatives of erythromycin, their preparation process and their use as medicaments
CA2290136A CA2290136C (fr) 1998-11-24 1999-11-18 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US09/442,681 US6440941B1 (en) 1998-11-24 1999-11-18 Derivatives of erythromycin, their preparation process and their use as medicaments
ZA9907176A ZA997176B (en) 1998-11-24 1999-11-18 Derivatives of erythromycin, their preparation process and their use as medicaments.
JP11331141A JP2000159790A (ja) 1998-11-24 1999-11-22 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
DK99402907T DK1004592T3 (da) 1998-11-24 1999-11-23 Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
KR1019990052014A KR100587445B1 (ko) 1998-11-24 1999-11-23 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도
NO19995745A NO314729B1 (no) 1998-11-24 1999-11-23 Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, medikamenter som inneholder disse, samt nye forbindelser som ermellomprodukter vedfremstillingen av derivatene
PT99402907T PT1004592E (pt) 1998-11-24 1999-11-23 Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
AT99402907T ATE245160T1 (de) 1998-11-24 1999-11-23 Derivate von erythromycin, ihr verfahren zur herstellung, und ihre verwendung als arzneimittel
ES99402907T ES2198867T3 (es) 1998-11-24 1999-11-23 Nuevos derivados de eritromicina, su procedimiento de fabricacion, y su aplicacion como medicamentos.
RU99125547A RU2237672C2 (ru) 1998-11-24 1999-11-23 Новые производные эритромицина, способ их получения и применение в качестве медикаментов
MXPA99010813A MXPA99010813A (es) 1998-11-24 1999-11-23 Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamento.
HU9904392A HUP9904392A3 (en) 1998-11-24 1999-11-23 New derivatives of erythromycin, process for their production and their use as medicament
CNB99127394XA CN1165546C (zh) 1998-11-24 1999-11-23 红霉素的新衍生物,其制备方法及其制备药物的用途
IL133101A IL133101A (en) 1998-11-24 1999-11-23 History of erythromycin, the process of preparation and pharmaceutical preparations containing them
EP99402907A EP1004592B1 (fr) 1998-11-24 1999-11-23 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
DE69909577T DE69909577T2 (de) 1998-11-24 1999-11-23 Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
PL99336736A PL336736A1 (en) 1998-11-24 1999-11-24 Novel derivatives of erythromycin and method of obtaining them as well as their application as a drug
BR9905735-2A BR9905735A (pt) 1998-11-24 1999-11-24 Derivados da eritromicina, seu processo de preparação e sua aplicação como medicamentos
ARP990105985A AR021388A1 (es) 1998-11-24 1999-11-24 Derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamento
TR1999/02888A TR199902888A3 (tr) 1998-11-24 1999-11-24 Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.
US10/188,394 US6664398B2 (en) 1998-11-24 2002-07-02 Derivatives of erythromycin, their preparation process and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
FR2786188A1 FR2786188A1 (fr) 2000-05-26
FR2786188B1 true FR2786188B1 (fr) 2002-10-31

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9814782A Expired - Fee Related FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Country Status (24)

Country Link
US (2) US6440941B1 (enExample)
EP (1) EP1004592B1 (enExample)
JP (1) JP2000159790A (enExample)
KR (1) KR100587445B1 (enExample)
CN (1) CN1165546C (enExample)
AR (1) AR021388A1 (enExample)
AT (1) ATE245160T1 (enExample)
AU (1) AU772171B2 (enExample)
BR (1) BR9905735A (enExample)
CA (1) CA2290136C (enExample)
DE (1) DE69909577T2 (enExample)
DK (1) DK1004592T3 (enExample)
ES (1) ES2198867T3 (enExample)
FR (1) FR2786188B1 (enExample)
HU (1) HUP9904392A3 (enExample)
IL (1) IL133101A (enExample)
MX (1) MXPA99010813A (enExample)
NO (1) NO314729B1 (enExample)
PL (1) PL336736A1 (enExample)
PT (1) PT1004592E (enExample)
RU (1) RU2237672C2 (enExample)
TR (1) TR199902888A3 (enExample)
TW (1) TWI247747B (enExample)
ZA (1) ZA997176B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR20010013660A (ko) * 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-옥심 에리트로마이신 유도체
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
NO995745D0 (no) 1999-11-23
EP1004592B1 (fr) 2003-07-16
TWI247747B (en) 2006-01-21
NO314729B1 (no) 2003-05-12
IL133101A (en) 2007-02-11
EP1004592A1 (fr) 2000-05-31
CA2290136C (fr) 2010-07-20
MXPA99010813A (es) 2005-09-08
KR100587445B1 (ko) 2006-06-08
DK1004592T3 (da) 2003-10-27
PL336736A1 (en) 2000-06-05
US6440941B1 (en) 2002-08-27
ES2198867T3 (es) 2004-02-01
TR199902888A2 (xx) 2000-06-21
FR2786188A1 (fr) 2000-05-26
DE69909577T2 (de) 2004-06-03
CA2290136A1 (fr) 2000-05-24
AR021388A1 (es) 2002-07-17
AU5952299A (en) 2000-05-25
ATE245160T1 (de) 2003-08-15
RU2237672C2 (ru) 2004-10-10
ZA997176B (en) 2000-11-20
HUP9904392A3 (en) 2001-08-28
DE69909577D1 (de) 2003-08-21
TR199902888A3 (tr) 2000-06-21
BR9905735A (pt) 2000-08-08
NO995745L (no) 2000-05-25
HU9904392D0 (en) 2000-01-28
CN1263101A (zh) 2000-08-16
KR20000057017A (ko) 2000-09-15
PT1004592E (pt) 2003-12-31
US20030050254A1 (en) 2003-03-13
HUP9904392A2 (hu) 2000-05-28
AU772171B2 (en) 2004-04-08
IL133101A0 (en) 2001-03-19
JP2000159790A (ja) 2000-06-13
US6664398B2 (en) 2003-12-16
CN1165546C (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
CA2290136A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2164638A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
MA32088B1 (fr) Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique
MA32090B1 (fr) Dérivés de carboxamides azabicycliques, leur préparation et leur application en thérapeutique
KR960037682A (ko) 축합 6환 화합물 및 그의 제조방법
EP2292593A3 (en) Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
EP2228064A3 (en) Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
MXPA04009490A (es) Compuesto de acido carbamico que comprenden un enlace de piperazina como inhibidores de histona desacetilasa.
FR2926554B1 (fr) Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
KR920014810A (ko) 항균제
CA2412932A1 (en) Pleuromutilin derivatives having antibacterial activity
KR890014486A (ko) N-시클로프로필아닐, 및 1-시클로프로필-퀴놀론카르복실산 및 그의 유도체의 제조에 있어서 n-시클로프로필아닐린의 용도
CA2231562A1 (fr) Nouveaux derives de la 5-o-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
FR2854634A1 (fr) Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR890000482A (ko) (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드
KR930019634A (ko) 이미다졸릴 치환 페닐아세트아미드
KR830009015A (ko) 메르캅토 아실 카르니틴 에스테르류의 제조방법
CA2363284A1 (fr) Procede de synthese de derives n-(mercaptoacyl)-amino-acides a partir d'acides acryliques alpha-subtitues
EP1215213A3 (fr) Dérivés bicycliques d'amino-pyrazones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
KR830006183A (ko) 카르니틴의 알콕시-아실 유도체의 에스테르 제조방법
MA28326A1 (fr) Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR960029319A (ko) 4-아미노벤조일구아니딘 유도체
CA2273985A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP1277746A3 (fr) Nouveaux dérivés de N-benzylpiperazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse